NCT02407561View on ClinicalTrials.gov

Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Rectal AdenocarcinomaAnal AdenocarcinomaAnal Squamous Cell Carcinoma
Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors
All Listed Sponsors
lead

Castle Biosciences Incorporated

INDUSTRY